Richard Lowenthal in Podcasts
personRichard Lowenthal is the CEO of ARS Pharmaceuticals, involved in developing nasal spray treatments.
Mentions Over Time
1
mentions
Mentions in Podcasts
Vanguards of Health Care by Bloomberg Intelligence
ARS Pharma’s Clinical Differentiation
I'm Anne Hunter-Van Kirk, Senior Biopharmaceuticals Analyst at Bloomberg Intelligence, the in-house equity research division of Bloomberg, and I'm very pleased to welcome today's guest, Richard Lowenthal, CEO of ARS Pharmaceuticals.